Olívia Basso Rocha

Ms. Olívia Basso Rocha

Universidade Federal de Goias
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
LSLívia do Carmo Silva
Lívia do Carmo Silva
AOAmanda Alves de Oliveira
Amanda Alves de Oliveira
Dienny de SouzaDienny de Souza
Dienny de Souza
KBKatheryne lohany Barros barbosa
Katheryne lohany Barros barbosa
KSKleber Santiago Freitas Silva
Kleber Santiago Freitas Silva
MPMaristela Pereira
Maristela Pereira
Paracoccidioidomycosis is a neglected disease that causes economic and social impacts, mainly affecting people of certain social segments, such as rural workers. The limitations of antifungals, such as toxicity, drug interactions, restricted routes of administration, and the reduced bioavailability in target tissues, have become evident in clinical settings. These factors, added to the fact that Paracoccidioidomycosis (PCM) therapy is a long process, lasting from months to years, emphasize the need for the research and development of new molecules. Researchers have concentrated efforts on the identification of new compounds using numerous tools and targeting important proteins from Paracoccidioides, with the emphasis on enzymatic pathways absent in humans. This review aims to discuss the aspects related to the identification of compounds, methodologies, and perspectives when proposing new antifungal agents against PCM.

13 January 2023 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
Olívia Basso RochaOlívia Basso Rocha
Olívia Basso Rocha
KSKleber Santiago Freitas Silva
Kleber Santiago Freitas Silva
TSThaynara Santos
Thaynara Santos
Dayane MoraesDayane Moraes
Dayane Moraes
LALeandro Do Prado Assunção
Leandro Do Prado Assunção
MPMaristela Pereira
Maristela Pereira
Background: Paracoccidioidomycosis is a systemic mycosis caused by the inhalation of conidia of the genus Paracoccidioides. During the infectious process, fungal cells use several carbon sources, leading to the production of propionyl-CoA. The latter is metabolized by the methylcitrate synthase, a key enzyme of the methylcitrate cycle. We identified an inhibitor compound (ZINC08964784) that showed antifungal activity against P. brasiliensis. Methods: This work aimed to understand the fungal metabolic response of P. brasiliensis cells exposed to ZINC08964784 through a proteomics approach. We used a glucose-free medium supplemented with propionate in order to simulate the environment found by the pathogen during the infection. We performed pyruvate dosage, proteolytic assay, dosage of intracellular lipids and quantification of reactive oxygen species in order to validate the proteomic results. Results: The proteomic analysis indicated that the fungal cells undergo a metabolic shift due to the inhibition of the methylcitrate cycle and the generation of reactive species. Proteolytic enzymes were induced, driving amino acids into degradation for energy production. In addition, glycolysis and the citric acid cycle were down-regulated while ß-oxidation was up-regulated. The accumulation of pyruvate and propionyl-CoA led the cells to a state of oxidative stress in the presence of ZINC08964784. Conclusions: The inhibition of methylcitrate synthase caused by the compound promoted a metabolic shift in P. brasiliensis damaging energy production and generating oxidative stress. Hence, the compound is a promising alternative for developing new strategies of therapies against paracoccidioidomycosis.

31 December 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
LSLívia do Carmo Silva
Lívia do Carmo Silva
KSKleber Santiago Freitas Silva
Kleber Santiago Freitas Silva
Olívia Basso RochaOlívia Basso Rocha
Olívia Basso Rocha
KBKatheryne lohany Barros barbosa
Katheryne lohany Barros barbosa
ARAndrew Matheus Frederico Rozada
Andrew Matheus Frederico Rozada
MPMaristela Pereira
Maristela Pereira
Background: Paracoccidioidomycosis is a neglected mycosis with a high socioeconomic impact that requires long-term treatment with antifungals that have limitations in their use. The development of antifungals targeting essential proteins that are present exclusively in the fungus points to a potentially promising treatment. Methods: The inhibitor of the enzyme homoserine dehydrogenase drove the synthesis of N’-(2-hydroxybenzylidene)-4-methoxy-1-naphthohydrazide (AOS). This compound was evaluated for its antifungal activity in different species of Paracoccidioides and the consequent alteration in the proteomic profile of Paracoccidioides brasiliensis. Results: The compound showed a minimal inhibitory concentration ranging from 0.75 to 6.9 μM with a fungicidal effect on Paracoccidioides spp. and high selectivity index. AOS differentially regulated proteins related to glycolysis, TCA, the glyoxylate cycle, the urea cycle and amino acid metabolism, including homoserine dehydrogenase. In addition, P. brasiliensis inhibited protein synthesis and stimulated reactive oxygen species in the presence of AOS. Conclusions: AOS is a promising antifungal agent for the treatment of PCM, targeting important metabolic processes of the fungus.

16 August 2023 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
LSLívia do Carmo Silva
Lívia do Carmo Silva
Olívia Basso RochaOlívia Basso Rocha
Olívia Basso Rocha
IPIgor Godinho Portis
Igor Godinho Portis
TSThaynara Santos
Thaynara Santos
KSKleber Santiago Freitas Silva
Kleber Santiago Freitas Silva
MPMaristela Pereira
Maristela Pereira
Background: The treatment of paracoccidioidomycosis (PCM) is a challenge, and the discovery of new antifungal compounds is crucial. The phenacylideneoxindoles exhibited promising antifungal activity against Paracoccidioides spp., but their mode of action remains unknown. Methods: Through proteomic analysis, we investigated the effects of (E)-3-(2-oxo-2-phenylethylidene)indolin-2-one on P. brasiliensis. In addition, we investigated the metabolic alterations of P. brasiliensis in response to the compound. Furthermore, the effects of the compound on the membrane, ethanol production, and reactive oxygen species (ROS) production were verified. Results: We identified differentially regulated proteins that revealed significant metabolic reorganization, including an increase in ethanol production, suggesting the activation of alcoholic fermentation and alterations in the rigidity of fungal cell membrane with an increase of the ergosterol content and formation of ROS. Conclusions: These findings enhance our understanding of the mode of action and response of P. brasiliensis to the investigated promising antifungal compound, emphasizing its potential as a candidate for the treatment of PCM.

18 January 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
Olívia Basso RochaOlívia Basso Rocha
Olívia Basso Rocha
KSKleber Santiago Freitas Silva
Kleber Santiago Freitas Silva
Dayane MoraesDayane Moraes
Dayane Moraes
CBClayton Luiz Borges
Clayton Luiz Borges
CSCelia Maria De Almeida Soares
Celia Maria De Almeida Soares
MPMaristela Pereira
Maristela Pereira
Paracoccidioidomycosis (PCM) is a fungal disease caused by organisms of the genus Paracoccidioides spp. The treatment of the disease is lengthy and includes several adverse effects. Various methodologies focus on the search for new treatments against fungal disease, including the repositioning of drugs. Our group showed the fungicidal effect of mebendazole in P. brasiliensis cells. Thus, understanding the effect of exposing fungal cells to mebendazole is significant for further studies in order to demonstrate it as a potential drug for the treatment of PCM. A proteomic analysis of P. brasiliensis exposed to mebendazole was carried out. Analyses showed that exposure strongly affected the pathways related to energy production, such as glycolysis, fermentation, and the electron transport chain. The quantification of adenosine triphosphate (ATP) and mitochondrial activity demonstrated that the drug alters the electron chain, resulting in an increase in oxidative stress. Enzymes such as superoxide dismutase (SOD) and cytochrome c oxidase (Cyt C) were repressed in cells exposed to mebendazole. The concentration of ethanol produced by the cells under treatment demonstrated that the attempt to produce energy through fermentation is also arrested. Thus, the drug inhibits fungal growth through changes in energy metabolism, making it a promising compound for use in the treatment of PCM.

10 July 2023 in Future Microbiology
Verified
Journal Article
Closed access
Marcos de Carvalho JúniorMarcos de Carvalho Júnior
Marcos de Carvalho Júnior
LSLívia do Carmo Silva
Lívia do Carmo Silva
Olívia Basso RochaOlívia Basso Rocha
Olívia Basso Rocha
AOAmanda A Oliveira
Amanda A Oliveira
IPIgor G Portis
Igor G Portis
MPMaristela Pereira
Maristela Pereira
Aim: To access the metabolic changes caused by a chalcone derivative (LabMol-75) through a proteomic approach. Methods: Proteomic analysis was performed after 9 h of Paracoccidioides brasiliensis y... Graphical abstract